ÂÜÀòÂÒÂ×

Dr. William Mezzanotte joined the Board of BELLUS Health in March 2021.

Dr. Mezzanotte is the Global Head of Research and Development and Chief Medical Officer at CSL Behring where he is responsible for developing and executing the Research & Development strategy and portfolio, including the identification and development of all R&D platforms, skills and expertise necessary for success.

In April 2017, Dr. Mezzanotte joined CSL Behring as Head of Clinical Development, responsible for clinical science, statistics and clinical operations across the portfolio. Most recently, he served as Senior Vice President and Head of Development, where he oversaw regulatory, project management, clinical science & operations, plasma, recombinant protein and gene therapy pharmaceutical development activities worldwide.